PIII
Income statement / Annual
Last year (2023), P3 Health Partners Inc.'s total revenue was $1.27 B,
an increase of 20.66% from the previous year.
In 2023, P3 Health Partners Inc.'s net income was -$57.77 M.
See P3 Health Partners Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$1.27 B
|
$1.05 B
|
$491.06 B
|
$485.54 M
|
$145.48 M
|
$87.70 M
|
| Cost of Revenue |
$1.23 B |
$1.14 B |
$668.07 M |
$485.30 M |
$141.03 M |
$0.00 |
| Gross Profit |
$31.64 M |
-$95.01 M |
$490.40 B |
$243,696.00 |
$4.45 M |
$87.70 M |
| Gross Profit Ratio |
0.02 |
-0.09 |
1 |
0 |
0.03 |
1 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$122.36 M
|
$157.30 M
|
$53.39 B
|
$53.39 M
|
$36.42 M
|
$28.54 M
|
| Selling & Marketing
Expenses |
$3.23 M
|
$5.10 M
|
$1.50 B
|
$1.50 M
|
$801,685.00
|
$1.87 M
|
| Selling, General &
Administrative Expenses |
$125.60 M
|
$162.40 M
|
$54.89 B
|
$54.89 M
|
$37.23 M
|
$30.41 M
|
| Other Expenses |
$73.97 M |
$1.13 B |
$464.76 B |
$465.77 M |
$147.79 M |
-$103,734.00 |
| Operating Expenses |
$199.57 M |
$1.30 B |
$519.65 B |
$520.66 M |
$185.02 M |
$137.41 M |
| Cost And Expenses |
$1.43 B |
$1.30 B |
$519.65 B |
$520.66 M |
$185.02 M |
$137.41 M |
| Interest Income |
$0.00 |
$11.40 M |
$0.00 |
$2.53 M |
$2.53 M |
$0.00 |
| Interest Expense |
$15.99 M |
$11.40 M |
$10.68 M |
$2.53 M |
$2.53 M |
$0.00 |
| Depreciation &
Amortization |
$86.68 M
|
$87.29 M
|
$8.72 M
|
$795,172.00
|
$399,177.00
|
$342,196.00
|
| EBITDA |
-$81.07 M
|
-$1.46 B
|
-$184.61 M
|
-$28.08 M
|
-$39.04 M
|
-$49.37 M
|
| EBITDA Ratio |
-0.06 |
-0.15 |
-0.06 |
-0.07 |
-0.27 |
-0.56 |
| Operating Income Ratio
|
-0.13
|
-1.49
|
-0.06
|
-0.07
|
-0.27
|
-0.57
|
| Total Other
Income/Expenses Net |
-$15.87 M
|
$1.22 M
|
-$31.22 B
|
-$2.82 M
|
-$2.44 M
|
-$59,501.00
|
| Income Before Tax |
-$183.73 M |
-$1.56 B |
-$31.41 B |
-$45.38 M |
-$41.97 M |
-$49.77 M |
| Income Before Tax Ratio
|
-0.15
|
-1.49
|
-0.06
|
-0.09
|
-0.29
|
-0.57
|
| Income Tax Expense |
$2.70 M |
$1.90 M |
-$31.40 B |
-$4.00 M |
$2.63 M |
-$6.02 M |
| Net Income |
-$57.77 M |
-$270.13 M |
-$10.08 M |
-$31.41 M |
-$41.97 M |
-$43.80 M |
| Net Income Ratio |
-0.05 |
-0.26 |
-0 |
-0.06 |
-0.29 |
-0.5 |
| EPS |
-0.61 |
-6.5 |
-0.24 |
-0.79 |
-0.88 |
-0.64 |
| EPS Diluted |
-0.2 |
-6.5 |
-0.24 |
-0.79 |
-0.88 |
-0.64 |
| Weighted Average Shares
Out |
$94.89 M
|
$41.58 M
|
$41.58 M
|
$39.53 M
|
$47.59 M
|
$68.16 M
|
| Weighted Average Shares
Out Diluted |
$294.59 M
|
$41.58 M
|
$41.58 M
|
$39.53 M
|
$47.59 M
|
$68.16 M
|
| Link |
|
|
|
|
|
|
